Advances in Clinical and Experimental Medicine

Adv Clin Exp Med
Impact Factor (IF) – 1.514
Index Copernicus (ICV 2018) – 157.72
MNiSW – 40
Average rejection rate – 84.38%
ISSN 1899–5276 (print)
ISSN 2451-2680 (online)
Periodicity – monthly

Download PDF

Advances in Clinical and Experimental Medicine

2019, vol. 28, nr 4, April, p. 461–467

doi: 10.17219/acem/78157

Publication type: original article

Language: English

Download citation:

  • BIBTEX (JabRef, Mendeley)
  • RIS (Papers, Reference Manager, RefWorks, Zotero)

Creative Commons BY-NC-ND 3.0 Open Access

Effectiveness comparison of various atrial fibrillation ablation methods in patients with common venous trunk

Edward Koźluk1,A,B,C,D,E,F, Dorota Zyśko2,A,C,D,E,F, Agnieszka Piątkowska1,2,A,B,E,F, Marek Kiliszek3,A,B,E,F, Piotr Lodziński1,A,B,E,F, Sylwia Małkowska1,A,B,E,F, Paweł Balsam1,A,B,E,F, Dariusz Rodkiewicz1,A,B,E,F, Małgorzata Żukowska4,A,B,E,F, Grzegorz Opolski1,A,E,F

1 1st Chair and Department of Cardiology, Medical University of Warsaw, Poland

2 Chair of Emergency Medicine, Wroclaw Medical University, Poland

3 Department of Cardiology and Internal Diseases, Military Institute of Medicine, Warszawa, Poland

4 2nd Faculty of Radiology, Medical University of Warsaw, Poland


Background. Atrial fibrillation (AF) is a common clinical problem. The left atrium anatomy makes up a factor that may significantly affect the effectiveness of the AF ablation.
Objectives. The aim of the study was to evaluate a long-term effectiveness ablation in patients with common pulmonary vein trunk (CPVT) and AF.
Material and Methods. The outcomes of 129 procedures in 95 patients with CPVT out of 1,475 procedures carried out in 1,150 patients with AF treated with ablation, were analyzed. Ablation with CARTO 3 system (Johnson & Johnson, New Brunswick, USA), cryoballoon, and the circular multipolar duty-cycled radiofrequency-based pulmonary vein ablation producer with catheter (PVAC) were considered as advanced methods. The following data was recorded for every patient: age, gender, AF duration and type, previous antiarrhythmic drugs, weight, height, any prior cardioversion, and comorbidities, including hypertension, diabetes, hypothyreosis, thyrotoxicosis, heart failure, and stroke/transient ischemic attack. The following anatomical factors were assessed: the presence of patent foramen ovale (PFO) and localization of the CPVT on the basis of venography or computed tomography (CT). In the 1st year after ablation, 24-h Holter monitoring was performed 3–5 times, and the patients were encouraged to visit their doctor or an emergency department if a cardiac arrhythmia occurred. Long-term ablation effectiveness was assessed based on a telephone interview and patients’ answers to the questionnaires including 12-lead electrocardiography (ECG).
Results. Sinus rhythm was maintained in 44 patients (43.6 %) after a median of 42 months (range 12–120). A lower number of clinical factors (odds ratio [OR] range 0.09; 95% confidence interval [CI] 0.02–0.56; p < 0.01), and advanced ablation methods (OR 3.1; 95% CI 1.4–7.1; p < 0.01) were related to a better longterm effectiveness.
Conclusion. The long-term effectiveness of pulmonary vein (PV) isolation in patients with AF and CPVT is higher when advanced ablation techniques are used. Accumulation of clinical factors was found to be the most tremendous predictor of AF recurrence.

Key words

long-term outcome, atrial fibrillation, ablation, common trunk

References (30)

  1. Chen LY, Sotoodehnia N, Bůžková P, et al. Atrial fibrillation and the risk of sudden cardiac death: The atherosclerosis risk in communities study and cardiovascular health study. JAMA Intern Med. 2013;173(1):29–35.
  2. Camm AJ, Lip GY, De Caterina R, et al. 2012 focused update of the ESC Guidelines for the management of atrial fibrillation: An update of the 2010 ESC Guidelines for the management of atrial fibrillation. Developed with the special contribution of the European Heart Rhythm Association. Eur Heart J. 2012;33(21):2719–2747.
  3. European Heart Rhythm Association; European Association for Cardio-Thoracic Surgery; Camm AJ, Kirchhof P, Lip GY, et al. Committee for Practice Guidelines. Guidelines for the management of atrial fibrillation: The Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC). Europace. 2010;12:1360–1420.
  4. Calkins H, Kuck KH, Cappato R, et al. 2012 HRS/EHRA/ECAS Expert Consensus Statement on Catheter and Surgical Ablation of Atrial Fibrillation: Recommendations for patient selection, procedural techniques, patient management and follow-up, definitions, endpoints, and research trial design. Europace. 2012;14:528–606.
  5. Sotomi Y, Inoue K, Ito N, et al. Incidence and risk factors for very late recurrence of atrial fibrillation after radiofrequency catheter ablation. Europace. 2013;15:1581–1586.
  6. Cai L, Yin Y, Ling Z, et al. Predictors of late recurrence of atrial fibrillation after catheter ablation. Int J Cardiol. 2013;164(1):82–87.
  7. Van Brabandt H, Neyt M, Devos C. Effectiveness of catheter ablation of atrial fibrillation in Belgian practice: A cohort analysis on administrative data. Europace. 2013;15:663–668.
  8. Fein AS, Shvilkin A, Shah D, et al. Treatment of obstructive sleep apnea reduces the risk of atrial fibrillation recurrence following catheter ablation. J Am Coll Cardiol. 2013;62(4):300–305.
  9. Chao TF, Cheng CC, Lin WS, et al. Associations among the CHADS(2) score, atrial substrate properties, and outcome of catheter ablation in patients with paroxysmal atrial fibrillation. Heart Rhythm. 2011;8(8):1155–1159.
  10. Beukema RP, Beukema WP, Smit JJ, et al. Efficacy of multi-electrode duty-cycled radiofrequency ablation for pulmonary vein disconnection in patients with paroxysmal and persistent atrial fibrillation. Europace. 2010;12:502–507.
  11. Monteiro MM, Saraiva C, Castelo Branco J, Cavaco D, Adragão P. Characterization of pulmonary vein morphology using multi-detector row CT study prior to radiofrequency ablation for atrial fibrillation. Rev Port Cardiol. 2009;28(5):545–559.
  12. den Uijl DW, Tops LF, Delgado V, et al. Effect of pulmonary vein anatomy and left atrial dimensions on outcome of circumferential radiofrequency catheter ablation for atrial fibrillation. Am J Cardiol. 2011;107(2):243–249.
  13. Sohns C, Sohns JM, Bergau L, et al. Pulmonary vein anatomy predicts freedom from atrial fibrillation using remote magnetic navigation for circumferential pulmonary vein ablation. Europace. 2013;15:1136–1142.
  14. Haïssaguerre M, Macle L, Jaïs P, et al. Electrophysiologically guided pulmonary vein isolation during sustained atrial fibrillation. J Cardiovasc Electrophysiol. 2003;14(3):255–260.
  15. Koźluk E, Gawrysiak M, Lodziński P, et al. The LocaLisa system as the key to shortening the procedure duration and fluoroscopy time during ablation of atrial fibrillation. Kardiol Pol. 2008;66(6):624–629 (discussion 630–631).
  16. Pappone C, Rosanio S, Oreto G, et al. Circumferential radiofrequency ablation of pulmonary vein ostia: A new anatomic approach for curing atrial fibrillation. Circulation. 2000;102(21):2619–2628.
  17. Koźluk E, Balsam P, Peller M, et al. Efficacy of multi-electrode duty-cycled radiofrequency ablation in patients with paroxysmal and persistent atrial fibrillation. Cardiol J. 2013;20:618–625.
  18. Koźluk E, Gaj S, Piatkowska A, et al. Evaluation of safety and the success rate of cryoballoon ablation of the pulmonary vein ostia in patients with atrial fibrillation: A preliminary report. Kardiol Pol. 2010;68(2):175–180.
  19. Koźluk E, Zyśko D, Piątkowska A, et al. Clinical and anatomical models of atrial fibrillation ablation in patients with common pulmonary vein trunk: Preliminary report. Pol Prz Kardiol. 2013;15(4):241–249.
  20. Breiman L, Friedman JH, Olshen A, Stone CJ. Classification and Regression Trees. Belmont, CA: Wadsworth; 1984.
  21. Pérez-Castellano N, Fernández-Cavazos R, Moreno J, et al. The COR trial: A randomized study with continuous rhythm monitoring to compare the efficacy of cryoenergy and radiofrequency for pulmonary vein isolation. Heart Rhythm. 2014;11(1):8–14.
  22. Malmborg H, Lönnerholm S, Blomström P, Blomström-Lundqvist C. Ablation of atrial fibrillation with cryoballoon or duty-cycled radiofrequency pulmonary vein ablation catheter: A randomized controlled study comparing the clinical outcome and safety. The AF-COR study. Europace. 2013;15:1567–1573.
  23. Lin G, Lu HH, Shen Y, Huang JF, Shi LS, Guo YN. Meta-analysis of the therapeutic effects of various methods for the treatment of chronic atrial fibrillation. Exp Ther Med. 2013;6(2):489–496.
  24. Pokushalov E, Romanov A, Artyomenko S, et al. Cryoballoon versus radiofrequency for pulmonary vein re-isolation after a failed initial ablation procedure in patients with paroxysmal atrial fibrillation. J Cardiovasc Electrophysiol. 2013;24(3):274–279.
  25. Tang RB, Liu DL, Dong JZ, et al. High-normal thyroid function and risk of recurrence of atrial fibrillation after catheter ablation. Circ J. 2010;74:1316–1321.
  26. Mikhaylov EN, Orshanskaya VS, Lebedev AD, Szili-Torok T, Lebedev DS. Catheter ablation of paroxysmal atrial fibrillation in patients with previous amiodarone-induced hyperthyroidism: A case-control study. J Cardiovasc Electrophysiol. 2013;24(8):888–893.
  27. Zimetbaum P. Amiodarone for atrial fibrillation. N Engl J Med. 2007;356(9):935–941.
  28. Wu JT, Dong JZ, Sang CH, Tang RB, Li XH, Ma CS. Efficacy of catheter ablation for atrial fibrillation in patients with a permanent pacemaker for sick sinus syndrome. Intern Med. 2013;52(20):2305–2310.
  29. Weerasooriya R, Khairy P, Litalien J, et al. Catheter ablation for atrial fibrillation: Are results maintained at 5 years of follow-up? J Am Coll Cardiol. 2011;57(2):160–166.
  30. Tondo C, Tritto M, Landolina M, et al. Rhythm-symptom correlation in patients on continuous monitoring after catheter ablation of atrial fibrillation. J Cardiovasc Electrophysiol. 2014;25(2):154–160.